TIDMGSK

RNS Number : 6785M

GlaxoSmithKline PLC

17 September 2019

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                    Mr D Jackson 
====  =======================================  ===================================================== 
 b)    Position/status                         PCA of Ms S Jackson (SVP, Global Communications 
                                                and CEO Office) 
====  =======================================  ===================================================== 
 c)    Initial notification/                   Initial notification 
        amendment 
====  =======================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  ===================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                          Ordinary shares of 25 pence each ('Ordinary 
        the financial                           Shares') 
        instrument                              ISIN: GB0009252882 
====  =======================================  ===================================================== 
 b)    Nature of the                           Award of Ordinary Shares under the Company's 
        transaction                             Share Value Plan 
====  =======================================  ===================================================== 
 c)    Price(s) and                             Price(s)                    Volume(s) 
        volume(s) 
====  =======================================   ==========================  ====================== 
   GBP17.434                                                                6,330 
   =======================================================================  ====================== 
 
 d)    Aggregated information                  N/A 
==== 
  Aggregated volume 
   Price 
 ====================================================================  ============================= 
 e)    Date of the transaction                 2019-09-03 
====  =======================================  ===================================================== 
 f)    Place of the                            London Stock Exchange (XLON) 
        transaction 
====  =======================================  ===================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQDLFFKKFXBBK

(END) Dow Jones Newswires

September 17, 2019 12:46 ET (16:46 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Gsk Charts.